Jorma Toppari
MD, PhD
jortop@utu.fi +358 29 450 2826 +358 40 180 2600 Kiinamyllynkatu 10 Turku Työhuone: C5 floor ORCID-tunniste: https://orcid.org/0000-0003-2228-334X |
Lastenendokrinologia; lisääntymisterveys; hormonaaliset haitta-aineet; kives; tyypin 1 diabetes
Professor Jorma Toppari (H-index 68) is an international expert in environmental endocrine disruption, male reproduction and type 1 diabetes. He is a principal investigator in a NIH-funded cohort study The Environmental Determinants of Diabetes in the Young (TEDDY) and in the Finnish Type 1 Diabetes Prediction and Prevention Study (DIPP). He is leading a joint Finnish-Danish birth cohort study exploring the genetic and environmental aspects of human reproduction.
The aim of our research is to identify risk factors of reproductive health and type 1 diabetes (T1D) to make risk management possible and prevent health problems. We are performing a comprehensive reproductive health study for 19-year-old men that we have followed up prospectively from pregnancy. We focus now our studies on sperm epigenome. We are studying the role of retinoblastoma protein (Rb) and E2F3 transcription factors in gonadal development and whether endocrine disruptors affect reproductive health. In the Finnish type 1 Diabetes Prediction and Prevention (DIPP) study and in The Environmental Determinants of Diabetes in the Young (TEDDY) study we are exploring the early determinants of T1D in large child cohorts with increased genetic risk.
Basic and clinical endocrinology, particularly pediatric and reproductive endocrinology, endocrine disruption, reproductive toxicology
- Early probiotic supplementation and the risk of celiac disease in children at genetic risk (2019)
- Nutrients
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Eturauhasen liikakasvun hoidossa käytettävät α1-adrenoreseptori-antagonistit (2019) Lääketieteellinen farmakologia ja toksikologia Ilpo Huhtaniemi, Jorma Toppari
(D2 Artikkeli ammatillisessa kokoomateoksessa) - FOXP3+Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children (2019)
- Frontiers in immunology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Genetic Contribution to the Divergence in Type 1 Diabetes Risk Between Children From the General Population and Children From Affected Families (2019)
- Diabetes
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - GnRH antagonist treatment of malignant adrenocortical tumors (2019)
- Endocrine-Related Cancer
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Introduction to Endocrine Toxicology and Endocrine Disruption (2019) Encyclopedia of Endocrine Diseases (Second Edition) Jorma Toppari
(D2 Artikkeli ammatillisessa kokoomateoksessa) - Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial (2019)
- The Lancet Child & Adolescent Health
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Low-saturated-fat and low-cholesterol diet does not alter pubertal development and hormonal status in adolescents (2019)
- Acta Paediatrica
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Maternal Dietary Supplement Use and Development of Islet Autoimmunity in the offspring: the TEDDY Study (2019)
- Pediatric Diabetes
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä ) - Metabolite-related dietary patterns and the development of islet autoimmunity (2019)
- Scientific Reports
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )



